Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2025-12-25 @ 12:25 PM
NCT ID:
NCT04331795
Group ID:
EG001
Title:
Group B
Description:
Hospitalized, non-critically ill patients with COVID-19 pneumonitis without risk factors for decompensation
Tocilizumab: Group B: Low-dose tocilizumab (beginning dose 80mg) Single dose is provisioned, patient is eligible to receive up to two doses, with re-evaluation of clinical and biochemical responses performed every 24 hours.
Second dose is provisioned if:
1. Increasing supplemental oxygen requirement or Tmax higher than baseline in the 24h following initial tocilizumab administration AND
2. CRP decrease is \< 25% at 24 hours following tocilizumab administration and CRP \> 40mg/L
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
20
Other Number Affected:
17
Other Number At Risk:
20
Study:
NCT04331795
Results Section:
NCT04331795
Adverse Events Module:
NCT04331795